Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nova Research Laboratories
United States
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
Nova Research Laboratories provides GLP ion channel screening and analytical services to support non-clinical cardiac safety and IND-enabling packages, including hERG screening and multi-ion channel QT Fingerprinting models that have contributed to ICH S7B and CiPA cardiac safety guidelines.[4][2][1]
- Therapeutic areas
- Cardiovascular
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
02
Partnerships
U.S. Food and Drug Administration (FDA) – ion channel screening support for CiPA safety assessment guidelines[2]Multiple pharmaceutical and biotechnology sponsors for IND-enabling ion channel safety packages[4][2]
Beyond the preview
Go deeper on Nova Research Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nova Research Laboratories.